Has Mehul Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $382,374 in general payments to Mehul Patel, MD across 562 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mehul Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mehul Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mehul Patel, MD

Interventional Cardiology · Germantown, TNNPI 1003097593

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 71.2% of it on its own, with 14 other manufacturers making up the rest. Among interventional cardiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$382,374in general payments, 2019–2025

Across 562 payments — averaging $680.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$272K
Medtronic$55K
Boston Scientific$36K
W. L. Gore & Associates, Inc.$11K
Abbott$5K
Medical Device Business Services, Inc.$2K
plus $808 from 9 others

$427,228in research payments, 2019–2025

Across 66 payments — averaging $6473.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$379K
Boston Scientific$48K

What the payments were for

Consulting fees$180,81547%
Speaking & faculty fees$82,84422%
Grants$2,4041%
Travel & lodging$104,33327%
Food & beverage$11,9783%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	292	$272,227
Medtronic(2 entities)	121	$54,733
Boston Scientific	60	$36,477
W. L. Gore & Associates, Inc.	8	$10,617
Abbott	35	$5,452
Medical Device Business Services, Inc.	32	$2,058
Penumbra, Inc.	2	$275
GE HealthCare	1	$210
Stryker	1	$117
Philips North America LLC	2	$73
Resmed Corp	2	$35
Boehringer Ingelheim	2	$34
Bayer	2	$32
AstraZeneca	1	$20
Atricure, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$223,101
WATCHMAN Access System$32,352
COREVALVE EVOLUT R$27,257
CoreValve Evolut$19,304
GORE CARDIOFORM Septal Occluder$7,444
GENERAL - THERAPIES$2,500
GORE CARDIOFORM ASD Occluder$2,160
MitraClip$1,983
Carto 3$1,647
PASCAL$1,596
AMPLATZER AMULET$1,319
TRICLIP$955
Product in Development$915
SAPIEN 3 Ultra RESILIA$849
HARMONY$775
Melody$765
GENERAL - STRUCTURAL HEART$526
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$507
Indigo System$275
ROTAPRO$136

How this compares

$382,374 in reported general payments places this provider in the 95th percentile of 207 interventional cardiology providers in Tennessee.

See all interventional cardiology providers in Tennessee →

Medicare billing

Part B allowed, 2024

$120,204

Medicare patients

287

Services billed

521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	102	$94,197
EntrestoSacubitril/Valsartan	59	$60,245
XareltoRivaroxaban	12	$12,512
ClopidogrelClopidogrel Bisulfate	201	$2,263
Spironolactone	77	$513
Metoprolol Succinate	27	$469
Carvedilol	34	$191
Penicillin V Potassium	13	$185
Warfarin Sodium	14	$117
Atorvastatin Calcium	15	$104
Furosemide	17	$84
Amoxicillin	15	$33

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Germantown

David KrausGermantown$87K
Basil PaulusGermantown$67K
James KlemisGermantown$24K
Justin MayGermantown$23K
Tamunoinemi Bob-ManuelGermantown$22K
Milton AddingtonGermantown$15K
Jimmy KerriganNashville$644K
Kashish GoelNashville$558K
Brian JeffersonNashville$547K
Malcolm FosterKnoxville$413K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →